Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Författare
Summary, in English
Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson's disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before the manifestation of the clinical symptoms, pointing to serious flaw/limitations in this approach.
Avdelning/ar
Publiceringsår
2016
Språk
Engelska
Publikation/Tidskrift/Serie
Molecular Neurodegeneration
Volym
11
Issue
1
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BioMed Central (BMC)
Ämne
- Neurology
Status
Published
Forskningsgrupp
- Neural Plasticity and Repair
ISBN/ISSN/Övrigt
- ISSN: 1750-1326